Pns1100055 316..320
نویسنده
چکیده
Patients undergoing oesophagectomy often have nutritional needs at the time of diagnosis and in the post-operative period. The aim of this article is to review the current literature and report on the author’s experience of routine feeding jejunostomy insertion following oesophagectomy. The records of forty-eight consecutive patients undergoing oesphagectomy under the author’s care were reviewed. Although the evidence of benefit of peri-operative feeding in patients undergoing oesophagectomy is limited, there is a clear need to establish a feeding route at the time of surgery. Oesophagectomy is associated with a mortality rate of 5–10% and a morbidity rate of 30–40% even in high-volume specialist centres. Over 50% of patients developing complications will require an alternative to oral feeding beyond 30 d. The enteral route is preferred in terms of safety and cost. A surgical feeding jejunostomy is associated with a low complication rate and a mortality rate of less than 1%. In forty-eight patients undergoing oesophagectomy the average weight loss at 6 months was 8.4 kg with only 8% regaining their pre-operative weight. Large reductions in weight at 6 months post-operatively were recorded irrespective of the development of post-operative complications or early recurrent disease. Routine jejunostomy insertion is recommended to ensure adequate nutrition in patients who develop post-operative complications and for those patients with long-term reduced appetite and poor oral intake.
منابع مشابه
INDOXACARB First draft prepared
Explanation.................................................................................................. 316 Evaluation for acceptable daily intake......................................................... 316 Biochemical aspects ....................................................................... 316 Absorption, distribution and excretion.................................. 316 Biotransfo...
متن کاملPediatr Drugs 2004; 6 (5): 303-330
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 304 1. Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....
متن کاملTerrorizing Wikileaks: Why the Embargo Against Wikileaks Will Fail
INTRODUCTION ..................................................................................... 306 I. ATTACKS ON TERRORIST WEBSITES .......................................... 307 A. Palestinian Islamic Jihad (PIJ) .......................................... 308 B. Al Qaeda ............................................................................. 309 II. WIKILEAKS ...........................
متن کاملThe Mughal Empire and Its Successors*
Political history . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302 The imperial structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 310 The social and economic framework . . . . . . . . . . . . . . . . . . . . . . . . . . 313 High culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315 State and religion . ...
متن کاملBiodrugs 2008; 22 (5): 315-329
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315 1. Peptides as Therapeutic Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....
متن کامل